CHEBI:140513 - α-D-GlcpNAc-(1→2)-α-L-Rhap-(1→4)-β-D-GalpNAcO[CH2]5NH2

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name α-D-GlcpNAc-(1→2)-α-L-Rhap-(1→4)-β-D-GalpNAcO[CH2]5NH2
ChEBI ID CHEBI:140513
ChEBI ASCII Name alpha-D-GlcpNAc-(1->2)-alpha-L-Rhap-(1->4)-beta-D-GalpNAcO[CH2]5NH2
Definition A linear trisaccharide derivative consisting of N-acetyl-α-D-glucosamine, α-L-rhamnose and N-acetyl-β-D-galactosamine residues linked sequentially (1→2) and (1→4) with the N-acetylgalactosamine residue linked glycosidically to a 5-aminopentyl group.
Stars This entity has been manually annotated by the ChEBI Team.
Supplier Information
Download Molfile XML SDF
Formula C27H49N3O15
Net Charge 0
Average Mass 655.690
Monoisotopic Mass 655.31637
InChI InChI=1S/C27H49N3O15/c1-11-18(35)22(39)24(45-26-16(29-12(2)33)20(37)19(36)14(9-31)42-26)27(41-11)44-23-15(10-32)43-25(40-8-6-4-5-7-28)17(21(23)38)30-13(3)34/h11,14-27,31-32,35-39H,4-10,28H2,1-3H3,(H,29,33)(H,30,34)/t11-,14+,15+,16+,17+,18-,19+,20+,21+,22+,23-,24+,25+,26+,27-/m0/s1
InChIKey DHPKOKHOEQYQPS-XCGWSNFQSA-N
SMILES O[C@@H]1[C@H]([C@@H](O[C@@H]([C@@H]1O[C@H]2[C@@H]([C@@H]([C@H]([C@@H](O2)C)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)NC(=O)C)CO)OCCCCCN)NC(C)=O
ChEBI Ontology
Outgoing α-D-GlcpNAc-(1→2)-α-L-Rhap-(1→4)-β-D-GalpNAcO[CH2]5NH2 (CHEBI:140513) is a glycoside (CHEBI:24400)
α-D-GlcpNAc-(1→2)-α-L-Rhap-(1→4)-β-D-GalpNAcO[CH2]5NH2 (CHEBI:140513) is a trisaccharide derivative (CHEBI:63571)
IUPAC Name
5-aminopentyl 2-acetamido-2-deoxy-α-D-glucopyranosyl-(1→2)-α-L-rhamnopyranosyl-(1→4)-2-acetamido-2-deoxy-β-L-galactopyranoside
Synonyms Sources
5-aminopentyl 2-acetamido-2-deoxy-α-D-glucopyranosyl-(1→2)-6-deoxy-α-L-mannopyranosyl-(1→4)-2-acetamido-2-deoxy-β-L-galactopyranoside IUPAC
5-aminopentyl N-acetyl-α-D-glucosaminyl-(1→2)-α-L-rhamnosyl-(1→4)-N-acetyl-β-L-galactosaminide ChEBI
α-D-GlcNAc-(1→2)-α-L-Rha-(1→4)-β-D-GalNAcO[CH2]5NH2 ChEBI
GlcNAcα1-2Rhaβ1-4GalNAcβO[CH2]5NH2 ChEBI
Citation Waiting for Citations Type Source
29333751 PubMed citation Europe PMC
Last Modified
11 April 2018